Randomized clinical trials in advanced and metastatic colorectal carcinoma

Surgical Oncology Clinics of North America

Volumn 11, Issue 1, 2002, Pages 173-191

  D'Angelica, Michael I ^a   Shoup, Margo C ^a   Nissan, Aviram ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; INTERFERON; IRINOTECAN; METHOTREXATE; MITOMYCIN C; SEMUSTINE;

CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; GASTROINTESTINAL DISEASE; HEPATIC ARTERY; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0036135120     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(03)00080-2     Document Type: Review

References (29)

1. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
2. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
3. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors
4. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
5. Therapy for advanced colorectal cancer
6. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases
7. Setting a new standard - Irinotecan (Campto) in the second-line therapy of colorectal cancer: Final results of two phase III studies and implications for clinical practice
8. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
9. Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein
10. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
11. Surgical therapy of hepatic colorectal metastasis
12. Cancer statistics, 2000
13. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature
14. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial
15. Preliminary results of a randomized study of intrahepatic infusion versus systemic infusion of 5-fluoro-2′-deoxyuridine for metastatic colorectal carcinoma
16. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
17. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer
18. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma
19. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer
20. Intra-arterial floxuridine vs. systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial
21. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial
22. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
23. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial
24. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
25. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer
26. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver
27. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver
28. ABC of colorectal cancer: Treatment of advanced disease